AIM2 Antibodies

Santa Cruz Biotechnology features a diverse variety of AIM2 monoclonal antibodies for advanced research in immunology and cellular signaling. AIM2 monoclonal antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AIM2, or absent in melanoma 2, is a crucial protein involved in the recognition of cytosolic DNA and the activation of the inflammasome, playing a significant role in the innate immune response. Its function is vital for the detection of pathogens and the regulation of inflammation, making AIM2 an important target for understanding various diseases, including autoimmune disorders and cancer. The study of AIM2 and its interactions can provide insights into therapeutic strategies for modulating immune responses. Researchers worldwide rely on AIM2 monoclonal antibodies to advance their understanding of immune system regulation. Current investigations focus on how AIM2 influences inflammatory pathways and disease progression. AIM2 research continues to reveal new potential therapeutic targets in immunology. Santa Cruz Biotechnology monoclonal antibodies support researchers in their mission to advance scientific understanding of immune system regulation and disease treatment.